Table 1 Categories and subcategories of stated irregularities
From: Prescriptions as quality indicators of pharmaceutical services in Polish community pharmacies
Irregularities category | Irregularities subcategories |
|---|---|
Pertaining to formal data in the prescription | • lack, incomplete or illegible patient data on the prescription, • lack or incorrect data of the person authorized to issue the prescription and/or lack of a signature/stamp of that person, • lack or incorrect data of the issued prescription, no signature or stamp of the doctor on the introduced changes, • lack of payer ID or incorrect entry, • incomplete data in the „Healthcare provider” field, • lack of healthcare provider stamp and non-compliance of the print-over data on the prescription with the stamp of the person issuing the prescription. |
Pertaining to prescribed reimbursed medications | • incorrect or incomplete data concerning prescribed medications, • prescribing psychotropic or narcotic drugs with other medications on one prescription, • incorrect prescribing of medications containing a psychotropic substance • and issuing a drug that was not on prescription. |
Pertaining to filling out of the prescription by an authorized person | • incorrect fulfillment of prescriptions, i.e. not in accordance with the established pricing found in the applicable regulations, • providing medications with reimbursement despite its full payment status, • lack of confirmation of prescription fulfillment by the person issuing the medication, • incorrect confirmation of the patients’ additional entitlements, • double use of the same prescription, • double referral for reimbursement of the same prescription, • the implementation of prescriptions issued by unauthorized physicians. |
Concerning the evaluation of the prescription and compliance of the data submitted to the National Health Fund | • inappropriate pricing of the medication, • lack of prescriptions based on, which the medication was issued, • failure to submit prescriptions for inspection, • providing inappropriate data from prescriptions to the National Health Fund, on the basis of which reimbursement is obtained, • delayed submission of reimbursement reports or corrections of these reports. |